# Evaluate the Safety and Effectiveness of the Biotrue ONEday for Astigmatism

> **NCT03681808** · NA · COMPLETED · sponsor: **Bausch & Lomb Incorporated** · enrollment: 242 (actual)

## Conditions studied

- Astigmatism

## Interventions

- **DEVICE:** Control
- **DEVICE:** Test

## Key facts

- **NCT ID:** NCT03681808
- **Lead sponsor:** Bausch & Lomb Incorporated
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-10
- **Primary completion:** 2019-12-16
- **Final completion:** 2019-12-16
- **Target enrollment:** 242 (ACTUAL)
- **Last updated:** 2021-01-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03681808

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03681808, "Evaluate the Safety and Effectiveness of the Biotrue ONEday for Astigmatism". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT03681808. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*